A Phase 1, Open-label, Drug Interaction Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants with Moderate to Severe Crohn's Disease
Clinical Trial Grant
Awarded By
Janssen Research & Development, LLC
Start Date
February 12, 2018
End Date
September 21, 2022
Awarded By
Janssen Research & Development, LLC
Start Date
February 12, 2018
End Date
September 21, 2022